LEGN
Legend Biotech
$20.39
+$1.12 (+5.81%)Oct 26, 2026
Key metrics
The numbers that frame LEGN today
- Market cap
- $3.95B
- Gross margin
- 56.6%
- EV / Sales
- 2.6
- ROIC
- -5.3%
- Div yield
- 0%
- Debt / equity
- 0.2
- 52wk Low
- $16.24
- 52wk High
- $37.46
Growth
Revenue and earnings trend for LEGN
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about LEGN
Is Legend Biotech a good buy?
Yes. Legend Biotech has strong quality, and it outweighs the weak momentum here. Growth looks excellent, which supports the long-term business case. We think Legend Biotech is selling at a high price, which cuts against the buy case.
What is the market capitalization of LEGN?
Legend Biotech's market capitalization is $3.95B.
What is the 52-week high for LEGN stock?
The 52-week high for Legend Biotech is $37.46. The current close of $20.39 is 45.6% below that high.
What is the 52-week low for LEGN stock?
The 52-week low for Legend Biotech is $16.24. The current close of $20.39 is 25.6% above that low.
Does LEGN stock pay dividends?
Legend Biotech does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for LEGN?
Legend Biotech's Debt / Equity ratio is 0.23.